European Commission launches stakeholder consultation
The European Commission launched stakeholder consultation on modalities of stakeholder involvement in the future voluntary HTA network (Directive 2011/24/EU). During a consultation period until August 1, 2012 it aims to receive contributions from a wide range of stakeholder groups and the public authorities and government-appointed bodies responsible for commissioning or executing HTA reports. For more […]
EUnetHTA is conducting a pilot by WP5
EUnetHTA is conducting a pilot by WP5, Relative Effectiveness Assessment (REA) of Pharmaceuticals, in which the draft tools that are being developed for relative effectiveness assessment of pharmaceuticals are tested. The first draft version of the report (rapid assessment of pazopanib for the treatment of advanced renal cell cancer) was ready in November 2011 and […]
WP5 Products
It is the remit of WP5 to develop tools for relative effectiveness assessment of pharmaceuticals. This document briefly presents the products of WP5 from EUnetHTA Joint Action 1. It is the remit of WP5 to develop tools for relative effectiveness assessment of pharmaceuticals. This document briefly presents the products of WP5 from EUnetHTA Joint Action […]
External Initiatives Management Policy
This is the policy on the management of EUnetHTA’s involvement in external initiatives. EUnetHTA’s involvement in external initiatives_Policy
Presentations 1-13 from the EMA-EUnetHTA meeting, 20 November 2012
These are all 13 presentations from the EMA-EUnetHTA meeting 20 November 2012. They are listed in the order as they are presented in the Summary report. Presentations 1-13 from the EMA-EUnetHTA meeting, 20 November 2012
EUnetHTA Strategy 2012 and beyond
This document presents the EUnetHTA Strategy 2012 and beyond. Common interests and policies in relation to HTA have been explored and developed at the strategic level in the European Union for ten years. EUnetHTA (European network for HTA) has been a major platform for supporting this process, since its inception in 2006. Operating currently through […]
The criteria to select and prioritise health technologies for additional evidence generation
This document is part of the JA1 Final Technical Report as an additional output for WP7. NOTE: For the full Technical Report, please follow this link. Selection-prioritisation criteria
Draft Procedure for Early Dialogue Pilots
This document is part of the JA1 Final Technical Report as an additional output for WP5. NOTE: For the full Technical Report, please follow this link. WP5 EARLY DIALOGUE PROCEDURE OCTOBER 2012
EUnetHTA Business Model Report as of May 2012
The document, prepared by the EUnetHTA Secretariat and further developed within the EUnetHTA Executive Committee and approved by the EUnetHTA Plenary Assembly (as a part of the EUnetHTA Strategy), describes a potential business model for EUnetHTA after JA2 with a view of being updated and detailed further during the different phases of the EUnetHTA development […]
EUnetHTA – INAHTA Memorandum of Understanding on cooperation
The Memorandum of Understanding on cooperation between EUnetHTA and INAHTA provides a framework to develop join activities. MOU EUnetHTA-INAHTA signed
